Medical Advisory Board
Chris Schultz, MD
Professor of Radiation Oncology at the Medical College of
Wisconsin
Yang Q, Feng Y, Schultz CJ, Li XA, Wu H,
Wang D.
Synergistic effect of 15-lipoxygenase 2 and radiation in killing
head-and-neck cancer.
Cancer Gene Ther. 2008 May;15(5):323-30. Epub 2008 Feb 22.
Vernon MR, Maheshwari M, Schultz CJ, Michel
MA, Wong SJ, Campbell BH, Massey BL, Wilson JF, Wang D.
Clinical outcomes of patients receiving integrated PET/CT-guided
radiotherapy for head and neck carcinoma.
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):678-84.
Possible fractionated regimens for image-guided
intensity-modulated radiation therapy of large arteriovenous
malformations.
Phys Med Biol. 2007 Sep 21;52(18):5667-82. Epub 2007 Sep 4.
Li XA, Qi XS, Pitterle M, Kalakota K,
Mueller K, Erickson BA, Wang D, Schultz CJ, Firat SY, Wilson JF.
Interfractional variations in patient setup and anatomic change
assessed by daily computed tomography.
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):581-91. Epub 2007 Feb 27.
Colman H, Berkey BA, Maor MH, Groves MD,
Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK; Radiation
Therapy Oncology Group.
Phase II Radiation Therapy Oncology Group trial of conventional
radiation therapy followed by treatment with recombinant
interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):818-24. Epub 2006 Aug 2.
Wang D, Schultz CJ, Jursinic PA, Bialkowski
M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, Li XA,
Wilson JF.
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):143-51.
Qi XS, Schultz CJ, Li XA.
An estimation of radiobiologic parameters from clinical outcomes for
radiation treatment planning of brain tumor.
Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1570-80.
Robins HI, Won M, Seiferheld WF, Schultz CJ,
Choucair AK, Brachman DG, Demas WF, Mehta MP.
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma
multiforme: RTOG protocol BR-0021.
Neuro Oncol. 2006 Jan;8(1):47-52.
Jursinic PA, Rickert K, Gennarelli TA,
Schultz CJ.
Effect of image uncertainty on the dosimetry of trigeminal neuralgia
irradiation.
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1559-67.
Zhu XR, Schultz CJ, Gillin MT.
Planning quality and delivery efficiency of sMLC delivered IMRT
treatment of oropharyngeal cancers evaluated by RTOG H-0022 dosimetric
criteria.
J Appl Clin Med Phys. 2004 Autumn;5(4):80-95. Epub 2004 Oct 1.
Harris GJ, Woo KI, Schultz CJ, Tayani R,
Cancel EM.
Late-onset chemosis in patients with head or neck tumors.
Ophthal Plast Reconstr Surg. 2004 Nov;20(6):436-41.
Souhami L, Seiferheld W, Brachman D,
Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff
P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr.
Randomized comparison of stereotactic radiosurgery followed by
conventional radiotherapy with carmustine to conventional radiotherapy
with carmustine for patients with glioblastoma multiforme: report of
Radiation Therapy Oncology Group 93-05 protocol.
Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):853-60.
Cooper JS, Pajak TF, Forastiere AA, Jacobs
J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M,
Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK; Radiation
Therapy Oncology Group 9501/Intergroup.
Postoperative concurrent radiotherapy and chemotherapy for high-risk
squamous-cell carcinoma of the head and neck.
N Engl J Med. 2004 May 6;350(19):1937-44.
Liu PT, Chivers FS, Roberts CC, Schultz CJ,
Beauchamp CP.
Imaging of osteoid osteoma with dynamic gadolinium-enhanced MR imaging.
Radiology. 2003 Jun;227(3):691-700.
DeAngelis LM, Seiferheld W, Schold SC,
Fisher B, Schultz CJ; Radiation Therapy Oncology Group Study 93-10.
Combination chemotherapy and radiotherapy for primary central nervous
system lymphoma: Radiation Therapy Oncology Group Study 93-10.
J Clin Oncol. 2002 Dec 15;20(24):4643-8.
Schultz CJ, Rumsewicz MP, Johnson KL, Jones
BJ, Gaspar YM, Bacic A.
Using genomic resources to guide research directions. The
arabinogalactan protein gene family as a test case.
Plant Physiol. 2002 Aug;129(4):1448-63.
Mehta MP, Shapiro WR, Glantz MJ, Patchell
RA, Weitzner MA, Meyers CA, Schultz CJ, Roa WH, Leibenhaut M, Ford J,
Curran W, Phan S, Smith JA, Miller RA, Renschler MF.
Lead-in phase to randomized trial of motexafin gadolinium and
whole-brain radiation for patients with brain metastases: centralized
assessment of magnetic resonance imaging, neurocognitive, and
neurologic end points.
J Clin Oncol. 2002 Aug 15;20(16):3445-53.
Michalski J, Purdy JA, Gaspar L, Souhami L,
Ballow M, Bradley J, Chao CK, Crane C, Eisbruch A, Fallowil D, Forster
K, Fowler J, Gillin MT, Graham ML, Harms WB, Huq MS, Kline RW, Mackie
TR, Mukherji S, Podogorsak EB, Roach M, Ryu J, Sandler H, Schultz CJ,
Schell M, Verhey LJ, Vicini F, Winter KA; Radiation Therapy Oncology
Group.
Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided
Radiation Therapy Committee.
Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):60-5. No abstract
available.
Boyd TS, Harari PM, Tannehill SP, Voytovich
MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ.
Planned postradiotherapy neck dissection in patients with advanced head
and neck cancer.
Head Neck. 1998 Mar;20(2):132-7.
Auchter RM, Lamond JP, Alexander E, Buatti
JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz
CJ, Loeffler JS, Mehta MP.
A multiinstitutional outcome and prognostic factor analysis of
radiosurgery for resectable single brain metastasis.
Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):27-35.
Schultz CJ.
Demonstration of a brachytherapy boost dose-response relationship in
glioblastoma multiforme: headed in the right direction.
Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):187-8.
Schultz CJ, Campbell BH, Freije JE, Brook
BJ, McAuliffe TL.
Risk factors which predict persistent cancer in the abnormal larynx
following definitive irradiation.
Eur J Cancer B Oral Oncol. 1995 Sep;31B(5):310-4.
Schultz CJ, Gaffney DK, Lindstrom MJ,
Kinsella TJ.
Iododeoxyuridine radiosensitization of human glioblastoma cells exposed
to acute and chronic gamma irradiation: mechanistic implications and
clinical relevance.
Cancer J Sci Am. 1995 Jul-Aug;1(2):151-61. Erratum in: Cancer J Sci Am.
1996 Jan-Feb;2(1):15.
Rock DB, Schultz CJ, Murray KJ, Wilson JF,
Cox JD.
Continuous split course irradiation for stage I and II Hodgkin's
disease: 20 year experience at the Medical College of Wisconsin.
Radiother Oncol. 1994 Mar;30(3):222-6.
Jacobs JP, Murray KJ, Schultz CJ, Wilson JF,
Goswitz MS, Stevens CW, Cox JD.
Central lymphatic irradiation for stage III nodular malignant lymphoma:
long-term results.
J Clin Oncol. 1993 Feb;11(2):233-8.